Literature DB >> 18217793

Statins, regulatory T cells and amyotrophic lateral sclerosis.

Mark R Goldstein, Luca Mascitelli, Francesca Pezzetta.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18217793     DOI： 10.2165/00002018-200831020-00007

Source DB:  PubMed          Journal:  Drug Saf        ISSN： 0114-5916            Impact factor:   5.606


× No keyword cloud information.
  8 in total

Review 1.  Role of glutamate on T-cell mediated immunity.

Authors:  Rodrigo Pacheco; Teresa Gallart; Carmen Lluis; Rafael Franco
Journal:  J Neuroimmunol       Date:  2007-02-14       Impact factor: 3.478

Review 2.  Regulatory T cell responses: potential role in the control of atherosclerosis.

Authors:  Ziad Mallat; Hafid Ait-Oufella; Alain Tedgui
Journal:  Curr Opin Lipidol       Date:  2005-10       Impact factor: 4.776

3.  Neuroprotective autoimmunity: naturally occurring CD4+CD25+ regulatory T cells suppress the ability to withstand injury to the central nervous system.

Authors:  Jonathan Kipnis; Tal Mizrahi; Ehud Hauben; Iftach Shaked; Ethan Shevach; Michal Schwartz
Journal:  Proc Natl Acad Sci U S A       Date:  2002-11-12       Impact factor: 11.205

4.  The effect of HMG-CoA reductase inhibitors on naturally occurring CD4+CD25+ T cells.

Authors:  Karin Mausner-Fainberg; Galia Luboshits; Adi Mor; Sophia Maysel-Auslender; Ardon Rubinstein; Gad Keren; Jacob George
Journal:  Atherosclerosis       Date:  2007-09-10       Impact factor: 5.162

5.  Myelin specific Th1 cells are necessary for post-traumatic protective autoimmunity.

Authors:  Jonathan Kipnis; Tal Mizrahi; Eti Yoles; Avraham Ben-Nun; Michal Schwartz; Auraham Ben-Nur
Journal:  J Neuroimmunol       Date:  2002-09       Impact factor: 3.478

Review 6.  A common vaccine for fighting neurodegenerative disorders: recharging immunity for homeostasis.

Authors:  Michal Schwartz; Jonathan Kipnis
Journal:  Trends Pharmacol Sci       Date:  2004-08       Impact factor: 14.819

7.  Statins, neuromuscular degenerative disease and an amyotrophic lateral sclerosis-like syndrome: an analysis of individual case safety reports from vigibase.

Authors:  I Ralph Edwards; Kristina Star; Anne Kiuru
Journal:  Drug Saf       Date:  2007       Impact factor: 5.606

Review 8.  Low-density lipoprotein cholesterol reduction: the end is more important than the means.

Authors:  John C LaRosa
Journal:  Am J Cardiol       Date:  2007-05-24       Impact factor: 2.778
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.